EU considers single patent and life sciences strategy
This article was originally published in Clinica
Executive Summary
The establishment of "a single patent for a single market" and the review of a progress report on the EU's life science and biotechnology strategy were at the centre of this week's meeting of the Competitiveness Council of Ministers. The growing clamour for a policy that supports EU innovation as the next framework programmes (FP6 and FP7) come on stream is backed by a petition signed by more than 300 CEOs and research directors.